Article
SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy
31 May 2022
Abstract excerpt
The type I interferon response plays a pivotal role in promoting antitumor immune activity in response to radiotherapy. The identification of approaches to boost the radiation-induced type I interferon response could help improve the efficacy of radiotherapy. Here we show that the histone methyltransferase SETDB1 is a potent suppressor of radiation-induced endogenous retrovirus expression. SETDB1 inhibition...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
